We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

State-of-the-Art Technology Revolutionizes Ultrasound-Guided Interventional Tool Guidance

By MedImaging International staff writers
Posted on 14 Nov 2023

The field of directed interventional tool guidance has struggled with complexities for many decades. Now, a state-of-the-art ultrasound-guided needle technology ushering in a new era of precision and safety is poised to reshape and revolutionize the future of interventional procedures.

DeepSight Technology’s (Santa Clara, CA, USA) proprietary NeedleVue solution combines innovative sensor technology with most interventional devices, enabling real-time verification of placement and reducing procedural guesswork significantly. Conventional technologies generally pose challenges like laborious calibration processes, lower sensitivity, and the need for precise angles of incidence. NeedleVue delivers across-the-board improvement using its omnidirectional functionality at any plausible ultrasound depth, improving functionality and ease of use in a true "plug-and-play" solution.


Image: The groundbreaking NeedleVue solution is poised to reshape and revolutionize the future of interventional procedures (Photo courtesy of DeepSight)
Image: The groundbreaking NeedleVue solution is poised to reshape and revolutionize the future of interventional procedures (Photo courtesy of DeepSight)

DeepSight's NeedleVue delineates a clear paradigm shift in needle guidance technology by delivering real-time, precision needle tracking that is portable as well as easy to use. The groundbreaking technology enhances the ability of clinicians to localize a surgical device during freehand procedures. The resulting improvement in tissue biopsy and therapeutic success leads to a reduction in patient complications, thereby creating better health outcomes. The technology comes as a breath of fresh air at a time when healthcare providers are focused on combining operational efficacy with improved patient outcomes.

"NeedleVue not only signifies a monumental leap in the evolution of interventional tool guidance but also substantiates our steadfast commitment to ensuring procedural success - benefiting patients, clinicians, and healthcare providers alike,” said Nader Sadrzadeh, the Chief Executive Officer at DeepSight Technology. “In a reality where procedural confidence is paramount, our solution stands out as a beacon of precision and reliability, effortlessly aligning with the multifaceted demands of modern healthcare."

Related Links:
DeepSight Technology 


New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Computed Tomography System
Aquilion ONE / INSIGHT Edition
New
Diagnostic Ultrasound System
MS1700C
Portable Color Doppler Ultrasound Scanner
DCU10

Latest Ultrasound News

Wearable Ultrasound Patch Enables Continuous Blood Pressure Monitoring

AI Image-Recognition Program Reads Echocardiograms Faster, Cuts Results Wait Time

Ultrasound Device Non-Invasively Improves Blood Circulation in Lower Limbs